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Abstract Background: Appropriate pain management after
total shoulder arthroplasty (TSA) facilitates rehabilitation and
may improve clinical outcomes. Questions/purposes: This pro-
spective, observational study evaluated a multimodal analgesia
clinical pathway for TSA. Methods: Ten TSA patients received
an interscalene nerve block (25 cm3 0.375% ropivacaine) with
intraoperative general anesthesia. Postoperative analgesia
included regularly scheduled non-opioid analgesics
(meloxicam, acetaminophen, and pregabalin) and opioids on
demand (oral oxycodone and intravenous patient-controlled
hydromorphone). Patients were evaluated twice daily to assess
pain, anterior deltoid strength, handgrip strength, and sensory
function. Results: The nerve block lasted an average of 18 h.
Patients had minimal pain after surgery; 0 (median score on a 0–
10 scale) in the Post-Anesthesia Care Unit (PACU) but increased
on postoperative day (POD) 1 to 2.3 (0.0, 3.8; median (25%,
75%)) at rest and 3.8 (2.1, 6.1) with movement. Half of the
patients activated the patient-controlled analgesia four or fewer
times in the first 24 h after surgery. Operative anterior deltoid
strength was 0 in the PACU but returned to 68% by POD 1.
Operative hand strength was 0 (median) in the PACU, but the
third quartile (75%) had normalized strength 49%of preoperative
value. Conclusions: Patients did well with this multimodal
analgesic protocol. Pain scores were low, half of the patients
used little or no intravenous opiate, and some patients had good
handgrip strength. Future research can focus on increasing
duration of analgesia from the nerve block, minimizing motor
block, lowering pain scores, and avoiding intravenous opioids.
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Introduction
Total shoulder arthroplasty (TSA) can cause moderate to
severe postoperative pain [22]. Appropriate pain manage-
ment improves patient satisfaction, facilitates postoperative
rehabilitation, and may improve clinically relevant out-
comes. Interscalene nerve blocks provide excellent postop-
erative analgesia and improve recovery for outpatient
shoulder surgery [7, 12]. Following TSA, patients often
receive intravenous opioids and transition to oral opioid
analgesics. Concomitant utilization of adjunctive analgesics
can minimize side effects from opioid administration and
improve the quality of analgesia [26]. Pre-emptive multi-
modal analgesia combined with peripheral nerve blockade
for total hip and knee arthroplasty was associated with
reductions in pain scores, opioid use, and length of hospital
stay [8]. Such a pathway for TSA patients may provide
similar benefits. A pathway based on continuous
interscalene nerve block for TSA resulted in decreased post-
operative pain, opioid requirements, opioid-related side ef-
fects [9], decreased time until readiness for discharge [10],
and enhanced range of motion (ROM) [11]. While a
HSSJ (2014) 10:100–106
DOI 10.1007/s11420-014-9381-0 HSS Journal
®
The Musculoskeletal Journal of Hospital for Special Surgery
Work was performed at the Hospital for Special Surgery, New York, NY.
Level of Evidence: Therapeutic study, level IV
Electronic supplementary material The online version of this article
(doi:10.1007/s11420-014-9381-0) contains supplementary material,
which is available to authorized users.
A. K. Goon, BA :D. M. Dines, MD : E. V. Craig, MD, MPH :
M. A. Gordon, MD : E. A. Goytizolo, MD :Y. Lin, MD, PhD :
J. T. YaDeau, MD, PhD (*)
Hospital for Special Surgery,
535 East 70th Street,
New York, NY 10021, USA
e-mail: yadeauj@hss.edu
E. Lin, MD
The New York School of Regional Anesthesia (NYSORA),
St. Luke’s-Roosevelt Hospital Center,
1111 Amsterdam Avenue,
New York, NY 10025, USA
D. M. Dines, MD : E. V. Craig, MD, MPH :M. A. Gordon, MD :
E. A. Goytizolo, MD :Y. Lin, MD, PhD : J. T. YaDeau, MD, PhD
Weill Cornell Medical College,
New York, NY 10065, USA
multimodal analgesic pathway with emphasis on peripheral
nerve blockade for TSA shows promise, the optimal tech-
nique remains to be defined.
A clinical pathway for TSA was generated based on
intraoperative general anesthetic with a peripheral nerve
block for postoperative analgesia [2, 4]. Ultrasound-guided
nerve blockade for shoulder surgery has a high success rate
(99.83%) and low complication rate (0.4% rate of temporary
numbness and tingling, no serious complications were ob-
served in 1,169 blocks (95% CI, 0–0.3%)) [14]. Ropivacaine
was used because it is a long-lasting local anesthetic, has
less toxicity than bupivacaine, and displays preferential sen-
sory blockade at lower concentrations [4, 9, 10, 13, 18].
TSA is often performed in the sitting “beach-chair” position.
Although general anesthesia and positive-pressure ventila-
tion in the sitting position are associated with a high rate of
cerebral oxygen desaturation events, compared with the
lateral decubitus position (80.3 vs 0%, respectively) [17],
cerebral oxygen desaturation is rare when general anesthesia
and positive-pressure ventilation are avoided [27]. Requests
for increased muscle relaxation can often be safely met by
increasing the isoflurane concentration, which provides sig-
nificant muscle relaxation [24] but allows for spontaneous
ventilation via laryngeal mask airway (LMA). The addition
of low-dose ketamine during surgery may reduce postoper-
ative opioid use [15, 16], improve surgical outcomes [15],
and decrease pain [16].
In addition to intraoperative administration of IV keta-
mine and ketorolac, oral analgesic adjuncts (meloxicam,
pregabalin, and acetaminophen) were included in the multi-
modal postoperative analgesic regimen. Prior studies
showed that nonsteroidal anti-inflammatory drugs reduce
postoperative pain [6, 20], pregabalin reduces opioid use
and nausea [28] and improves patient-reported analgesia
[1, 21, 26], and addition of acetaminophen to morphine
patient-controlled analgesia (PCA) reduces opioid intake
[19]. Despite the analgesia provided by an interscalene nerve
block, opioid supplementation is generally required after
TSA [4]. Thus, along with the preoperative interscalene
nerve block and adjunctive oral medications, postoperative
opioids (IV hydromorphone PCA+oral oxycodone) were
provided as needed.
A successful clinical pathway would facilitate rehabilita-
tion, heighten overall patient satisfaction, and promote an
expedited recovery process. This prospective cohort study
describes an analgesic and anesthetic protocol for TSA,
combining single-injection ultrasound-guided interscalene
nerve blockade and multimodal analgesia. Time until dis-
charge, extent of motor and sensory blockade, pain scores,
and analgesic use are reported.
Patients and Methods
After Institutional Review Board approval, informed written
consent was obtained in the holding (pre-surgical) area from
ten patients scheduled for primary TSA, aged 18 to 80 years
old, with enrollment from December 2011 to February 2012.
Inclusion cri ter ia included American Society of
Anesthesiologists (ASA) status of I, II, or III, planned use
of general anesthesia via LMA, planned peripheral nerve
block, and judged patient ability to follow study protocol.
Exclusion criteria included allergy or intolerance to one of
the study medications, hepatic or renal insufficiency, and
chronic opioid use (regular administration for longer than
3 months). There were 17 patients considered for the study,
but 4 were not eligible (two were taking opioids chronically
and two were ineligible as per the surgeon (one had a tendon
tear, one had rotator cuff repair)) and 3 declined to enroll.
Patients had an average age of 72 and an average Body Mass
Index (BMI) of 31 (Table 1); 50% of patients were female.
The following pathway was employed (Table 2). Prior to
induction of general anesthesia, patients received intrave-
nous midazolam sedation and an ultrasound-guided
interscalene block using a single injection of 25cm3
0.375% ropivacaine. The nerve block needle (22 G Chiba
(Hakko Co Ltd., Chikuma-shi, Nagano-ken, Japan) or
Stimuplex (B. Braun, Meisungen AG, Meisungen,
Germany)) was placed between the C5 and C6 nerve roots
(Fig. 1). Propofol was used to induce general anesthesia. A
LMA (The Laryngeal Mask Company, Limited., Le Rocher,
Victoria, Mahe, Seycelles) was placed, and anesthesia was
maintained with a propofol infusion and inhaled nitrous
oxide and isoflurane. Patients received ketamine (50 mg),
ketorolac (15–30 mg IV; 30 mg unless age>70 or weight<
60 kg), famotidine (20 mg), and anti-emetic prophylaxis
with IV dexamethasone (4 mg) and IV ondansetron (4 mg).
No intraoperative opioids were given. Intra-arterial catheters
(20 G catheter for A-Line, Smiths Medical International,
LTD, Lancashire, UK) were used to measure blood
pressure with the transducer situated at the external
auditory meatus, to approximate the level of the Circle of
Willis. Hypotension was managed with intravenous
ephedrine boluses and/or epinephrine infusions to maintain
a mean arterial pressure goal of 60 mmHg.
Multimodal analgesia included the interscalene nerve
block and intravenous PCA (IV hydromorphone; 0 basal rate
/ 0.2 mg / activation / 10 min lockout / maximum of 8
activations / h), first available to patients in the Post-
Table 1 Demographics
n=10
Age (years) 72±4
Gender (male/female; %) 50/50
Body Mass Index (BMI) 31±4
BMI (n (%))
Normal (<25) 1 (10%)
Overweight (25≥ and <30) 3 (30%)
Obese (30≥ and <40) 6 (60%)
Race
Caucasian 10
ASA 1/2/3 0/6/4
Length of stay (hours) 63±18
Duration of analgesia from nerve block (hours) 18±7
Duration of PCA (hours) 33±10
Data reported in mean (±standard deviation), unless otherwise noted
Abbreviation: PCA patient-controlled analgesia
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Anesthesia Care Unit (PACU). Oral oxycodone (5–10 mg q
4 h pro re nata) was available on demand. In addition, three
oral analgesic adjuncts were provided: meloxicam (7.5 to
15 mg daily for 5 days; 15 mg unless age is >70 or weight is
<60 kg), pregabalin (75–100 mg po q 8 h×3 days; 100 mg
unless age is >70 or weight is <60 kg), and acetaminophen
(650 mg q 6 h×3 days). Meloxicam was not given to patients
with renal insufficiency, peptic ulcer disease, or intolerance to
NSAIDs. Patients were instructed that hydromorphone and
oxycodone were available for moderate to severe pain but
could cause nausea, sedation, or itching. They were also told
that pain relief from oral oxycodone typically lasts longer than
pain relief from intravenous hydromorphone.
Patients were seen preoperatively, postoperatively on
the day of surgery, and twice daily after surgery on post-
operative days (POD) 1 and 2. The following information
was collected: age, sex, race, BMI, ASA status, and preop-
erative pain medication use. Patients were asked to rate
their pain at rest and with activity (numeric rating scale,
NRS, with 0 representing no pain and 10 representing the
worst imaginable pain). Sensory function was assessed by
pinprick in both the operative and nonoperative arms. Pin-
prick was measured using a paperclip, asking patients to
report normal sensation (=2), loss of sensation to pinprick
(=1), or loss of sensation to light touch (=0). Four derma-
tomes (C5, C6, C7, and C8) were evaluated. Handgrip
strength and anterior deltoid strength were measured in
both arms. Handgrip strength was assessed using the Base-
line Smedley Digital Hand Dynamometer Model 12-0286
(Fabrication Enterprises, Inc., White Plains, NY, USA),
whereas anterior deltoid strength was assessed using the
Lafayette Manual Muscle Test System Model 01163 (Lafa-
yette Instrument Company, Lafayette, IN, USA) in kilo-
gram-force units. To assess anterior deltoid strength,
patients were asked to make a vertical fist with arms bent
at a 90° angle and parallel to the floor. With the patients’
fist in contact with the handheld device, patients were
asked to press into the device using only their arm/shoulder
without leaning forward with their bodies. All of the as-
sessments described above were performed at each follow-
up visit. Patient-reported duration of analgesia from
interscalene block was also obtained.
Surgical Technique Relevant to Anesthetic and Analgesic
Outcomes
Procedures were carried out with the patient in the beach-
chair position at 35° to 40°. Proper soft tissue exposure,
critically important for anatomic total shoulder replace-
ment, is dependent upon proper surgical technique and
appropriate anesthesia. Muscle relaxation is especially
important in larger males and in patients with severe bony
deformity. Relaxation of the pectoralis major and
latissimus dorsi are critical for gaining proper exposure,
particularly for the glenoid, which is a small surface, deep
in the wound.
The deltopectoral approach was used. Once the
deltopectoral interval was developed, the subdeltoid scar
and bursa were excised. If external rotation was less than
25°, a subscapularis tendon lengthening was carried out
by skeletonizing the tendon off the lesser tuberosity with
or without an osteotomy of the lesser tuberosity. If the
rotation was more than 25°, a simple tenotomy and
release of the subscapularis muscle tendon unit was car-
ried out to expose the humerus and dislocate the joint
after the biceps tendon had been tenotomized. Occasion-
ally if the pectoralis major was very tight, the superior
portion was released.
Proper muscle relaxation is also important during place-
ment of the humeral components, as motion and stability
testing are hindered by muscle tension. After placement, the
subscapularis tendon is closed either through a drill hole in
the humeral neck, tendon to tendon or by transosseous
tendon to tendon repair. The long head of the biceps was
either let free or tenodesed.
Table 2 Clinical pathway protocol
Operating room anesthesia procedure
1. Single-injection ultrasound-guided interscalene block (25 cm3
0.375% ropivacaine between C5 and C6)
2. General anesthesia via LMA
Propofol/Midazolam induction
Propofol/nitrous oxide/Isoflurane maintenance
Spontaneous ventilation
3. Ketamine (50 mg)
4. IV Dexamethasone (4 mg), Ondansetron 4 mg, and Famotidine
(20 mg)
5. Ketorolac, if no contraindication (15–30 mg IV; 30 mg unless age is
>70 or weight is <60 kg)
Postoperative
1. Pregabalin (75–100 mg PO q 8 h×3 days; 100 mg unless age is >70
or weight is <60 kg)
2. Meloxicam, if no contraindication (7.5–15 mg daily×5 days; 15 mg
unless age is >70 or weight is <60 kg)
3. Acetaminophen (650 mg q 6 h×3 days)
4. Oxycodone (5–10 mg q 4 h PRN)
5. IV Hydromorphone PCA
Abbreviation: LMA laryngeal mask airway, IV Intravenous, PCA pa-
tient-controlled analgesia, PRN pro re nata (as necessary), PO per os
Fig. 1. Ultrasonographic image of interscalene nerve block. The C5
nerve root (arrow) and block needle (arrowheads) are indicated.
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In-hospital Postoperative Rehabilitation Protocol
Patients were maintained in a sling and swathe for comfort.
Therapy began on POD 1 under the care of our physical
therapists, directed by the findings at surgery. Depending
upon the native pathology and strength of repair, patients
started on a passive then active assistive ROM in elevation
and abduction in line with the scapula soon after the proce-
dure. External rotation was initially limited to 0° to 30°, to
allow subscapularis healing.
Statistical Methods
Descriptive statistics were used (SPSS 14.0 for Windows
(Chicago, IL)). Data are presented as mean (standard devi-
ation) unless one or more of the results were skewed, in
which case data are presented as median (lower and upper
quartiles). Skew (non-normal distribution) often occurs if
some of the data points are 0 and all others are positive.
Normality of distribution was determined by using the Sha-
piro–Wilk test. A significance of >0.05 indicated the data
were normally distributed; a significance of ≤0.05 indicated
a non-normal distribution.
Results
Data were analyzed for all ten enrolled patients. Patients
reported an average duration of analgesia from the nerve
block of 18 h and had an average hospital length of stay of
63 h.
Strength could not be assessed for one patient in the
PACU due to excessive sedation. One patient declined the
strength assessments on the morning of POD 2 due to
soreness in the shoulder muscles. The interscalene nerve
block reduced operative side anterior deltoid strength to 0
in the PACU, but strength returned to 68% by POD 1,
presumably as the effects of the nerve block dissipated
(Table 3). On the nonoperative side, the anterior deltoid
strength in the PACU was 86% of baseline, presumably
reflecting sedating effects from the general anesthetic. Hand
strength (operative side) was also reduced to a median of 0
in the PACU, but the third quartile (75%) had a normalized
strength of 49% of preoperative value. For comparison, the
median nonoperative handgrip strength in the PACU was
76% of baseline.
Dermatomes could not be assessed in the PACU for one
patient due to sedation. A majority of patients had reduced
sensation in their C6 and C7 dermatomes (Fig. 2). Dressings
allowed assessment of the C5 dermatome in three patients,
all of whom had decreased sensation. Only one patient had
some numbness/tingling in her fingers in the morning on
POD 1. All interscalene blocks were resolved by the evening
visit on POD 1.
Patients had less pain after the operation than before, in the
context of the multimodal analgesic protocol (Table 4). Pain
scores (at rest and with movement) were a median of 0 in the
PACU but increased on POD 1. Patients used highly variable
amounts of oral and intravenous opioids (Figs. 3 and 4). In the
first 24 h after the operation, three patients did not activate the
PCA at all, but two activated the PCA 20 or more times.
In the context of clinical trials, it is often instructive to
divide patients into responders and nonresponders [23]. We
propose a cut off of five activations in the first 24 h—patients
who activate the PCA 4 or fewer times in 24 h (i.e., at most
once every 6 h, on average) can be viewed as successfully
responding to the multimodal analgesic regimen. Using this
definition, half (5) of the patients were responders and
would likely not have needed the IV hydromorphone PCA.
Responders and nonresponders were similar on characteris-
tics such as age (72±5 and 71±3, respectively), gender
(60% and 40% female), BMI (31±5 and 32±4), and preop-
erative pain at rest (4.1±3.6 and 3.0±3.3), but the study is
underpowered for detailed analysis.
Discussion
This prospective, observational study evaluated a clinical
pathway for TSA patients that made extensive use of non-
opioid analgesics (interscalene nerve blockade, intraopera-
tive ketamine; postoperative meloxicam, pregabalin, and
acetaminophen). Most patients still used oral oxycodone
and intravenous hydromorphone. Information about time
until discharge, extent of motor and sensory blockade, pain
scores, and analgesic use was used to consider what an
optimal perioperative regimen would be for TSA patients.
All nerve blocks were successful, and on average patients
had less pain after the operation than they had prior to the
operation. Extent of use of intravenous hydromorphone (via
Table 3 Strength measurement
Number Median (25%, 75%)
Anterior deltoid strength operative
Preop (kgf) 10 5.0 (3.6, 6.3)
PACU (normalized %) 9 0% (0, 0)
POD1 (am; normalized %) 10 68% (58, 85)
POD1 (pm; normalized %) 10 63% (56, 76)
POD2 (am; normalized %) 9 77% (52,119)
Anterior deltoid strength (nonoperative)
Preop (kgf) 10 5.7 (4.8, 8.4)
PACU (normalized %) 9 86% (77, 90)
POD1 (am; normalized %) 10 102% (89, 117)
POD1 (pm; normalized %) 10 108% (80, 155)
POD2 (am; normalized %) 9 122% (76, 152)
Handgrip strength (operative)
Preop (kg) 10 17.9 (13.1, 25.6)
PACU (normalized %) 9 0% (0, 49)
POD1 (am; normalized %) 10 87% (74, 95)
POD1 (pm; normalized %) 10 81% (73, 99)
POD2 (am; normalized %) 9 90% (76, 99)
Handgrip strength (nonoperative)
Preop (kg) 10 20.9 (13.6, 23.2)
PACU (normalized %) 9 76% (67, 87)
POD1 (am; normalized %) 10 105% (91, 117)
POD1 (pm; nnrmalized %) 10 108% (99, 123)
POD2 (am; normalized %) 9 107% (94, 118)
Abbreviation: PACU post-anesthesia care unit, POD postoperative day,
kgf kilogram-force, kg kilogram
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PCA) was highly variable—some patients used none in the
first 24 h while others activated the PCA at least 20 times.
Limited information is available about other proposed
pathways for TSA. Ambulatory perineural brachial plexus
catheters have been found to promote readiness for dis-
charge after TSA [10] and have been advocated for use as
the primary analgesic for ambulatory TSA [5].
Prolonged postoperative motor blockade is not desirable
after TSA, particularly in the hand, as some patients find this
disconcerting. The interscalene nerve block (0.375%
ropivacaine) caused motor blockade of the anterior deltoid
which dissipated by the morning of POD 1, but it did not
universally cause distal motor blockade. Although the me-
dian handgrip strength on the day of surgery was 0%, the
Table 4 Pain scores and opioid use
Number Median (25%, 75%) Mean±standard deviation
Median NRS at rest (0–10)
Preop 10 2.5 (1.1, 6.4)
PACU 9 0.0 (0.0, 0.0)
POD1 (am) 10 2.3 (0.0, 3.8)
POD1 (pm) 10 2.5 (1.3, 4.1)
POD2 (am) 10 0.8 (0, 1.5)
Median NRS pain with movement (0–10)
Preop 10 8.5 (8.0, 9.9)
PACU 4 0.0 (0.0, 0.6)
POD1 (am) 10 3.8 (2.1, 6.1)
POD1 (pm) 10 3.3 (2.1, 5.6)
POD2 (am) 10 2.5 (1.1, 4.6)
Oral medication
Opioid intake (0–24 h; equivalent mg Morphine PO) 10 22.8±15.1
Opioid intake (24–48 h) 10 29.5±20.9
Opioid intake (total; 0–48 h) 10 52.3±32.7
PCA
Opioid intake (0–24 h; equivalent mg Morphine PO) 10 39.0±41.5
Opioid intake (24–48 h) 10 15.4±25.7
Opioid intake (total; 0–48 h) 10 54.4±58.6
PCA+PO combined
Opioid intake (0–24 h; equivalent mg Morphine PO) 10 61.8±49.3
Opioid intake (24–48 h) 10 44.9±38.7
Opioid intake (total; 0–48 h) 10 106.7±76.5
Abbreviation: NRS numeric rating scale, PACU post-anesthesia care unit, POD postoperative day, PO per os, PCA patient-controlled analgesia
Fig. 2. Pinprick assessment of sensory function on day of surgery in the PACU. The black bars indicate the number of patients with reduced
sensation in a dermatome. The white bars indicate the number of patients with normal sensation in a dermatome.
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75th% was 49% of baseline. This indicates that some of the
patients had partial preservation of distal (handgrip) strength.
Other studies have not examined the effect of the interscalene
block on anterior deltoid strength and handgrip strength. The-
se additional data provide a foundation for the development of
new studies directed at minimizing motor blockade.
There are a number of choices available for anesthesia
and analgesia after TSA. A recent review of analgesia after
shoulder surgery found the single-injection interscalene
block and continuous interscalene block to be the best op-
tions but noted that the continuous interscalene block is a
technically challenging procedure [3]. Alternative regional
anesthesia techniques include the suprascapular nerve block
and the supraclavicular block.
This was constructed as a pilot study. Future work could
include efforts to prolong the duration of analgesia from the
nerve blockade. This could reduce or eliminate intravenous
opioids and thereby facilitate early hospital discharge. Two
methods can be considered: continuous perineural infusion of
local anesthetic via a nerve block catheter [11] or use of
additives to the local anesthetic for the nerve block to prolong
the duration of analgesia [25]. Alternatively, one could inves-
tigate use of additional non-opioid analgesic adjuncts. Addi-
tional research could use control groups and focus on issues
such as: Does use of this clinical pathway reduce pain scores
or increase patient satisfaction? Does the clinical pathway lead
to improved rehabilitation or shorter length of stay? Does
increased distal strength improve patient satisfaction? Which
Fig. 4. Opioid use, 24–48 h. The black bars indicate the number of successful activations of hydromorphone PCA. The white bars indicate the
number of oral analgesic pills taken.
Fig. 3. Opioid use, 0–24 h. The black bars indicate the number of successful activations of hydromorphone PCA. The white bars indicate the
number of oral analgesic pills taken.
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components of the pathway are needed? Is brachial plexus
blockade needed in the context of multimodal analgesia?
This multimodal analgesic protocol provided excellent re-
sults for patients undergoing TSA. Pain scores were low, half of
the patients used little or no intravenous opiate, and some of the
patients had good handgrip strength. This work provides a basis
for continued research aiming at increased duration of analgesia
from the nerve block, lower pain scores, avoidance of intrave-
nous opioids, and minimal impairment of handgrip strength.
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